Remdesivir: an overview of patenting trends, clinical evidence on COVID-19 treatment, pharmacology and chemistry
{{output}}
By December 2021, the COVID-19 caused approximately 6.1 million deaths around the world. Several vaccines have been approved, but there is still a need for non-prophylactic treatments for COVID-19. Remdesivir is an antiviral drug approved for emergency use aga... ...
